Logo image of JBTM

JBT MAREL CORP (JBTM) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:JBTM - US4778391049 - Common Stock

157.42 USD
-0.71 (-0.45%)
Last: 1/22/2026, 8:04:00 PM
157.42 USD
0 (0%)
After Hours: 1/22/2026, 8:04:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to JBTM. JBTM was compared to 132 industry peers in the Machinery industry. JBTM may be in some trouble as it scores bad on both profitability and health. JBTM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year JBTM was profitable.
  • In the past year JBTM had a positive cash flow from operations.
  • JBTM had positive earnings in each of the past 5 years.
  • In the past 5 years JBTM always reported a positive cash flow from operatings.
JBTM Yearly Net Income VS EBIT VS OCF VS FCFJBTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

1.2 Ratios

  • JBTM has a Return On Assets of -1.35%. This is in the lower half of the industry: JBTM underperforms 73.48% of its industry peers.
  • Looking at the Return On Equity, with a value of -2.50%, JBTM is doing worse than 71.21% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 1.95%, JBTM is doing worse than 69.70% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for JBTM is below the industry average of 10.24%.
Industry RankSector Rank
ROA -1.35%
ROE -2.5%
ROIC 1.95%
ROA(3y)9.73%
ROA(5y)8.16%
ROE(3y)19.95%
ROE(5y)18.56%
ROIC(3y)5.49%
ROIC(5y)6.97%
JBTM Yearly ROA, ROE, ROICJBTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • In the last couple of years the Profit Margin of JBTM has declined.
  • JBTM has a worse Operating Margin (4.81%) than 62.88% of its industry peers.
  • JBTM's Operating Margin has declined in the last couple of years.
  • With a decent Gross Margin value of 35.80%, JBTM is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • In the last couple of years the Gross Margin of JBTM has grown nicely.
Industry RankSector Rank
OM 4.81%
PM (TTM) N/A
GM 35.8%
OM growth 3Y-9.42%
OM growth 5Y-7.55%
PM growth 3Y-16.35%
PM growth 5Y-5.58%
GM growth 3Y1.99%
GM growth 5Y3.46%
JBTM Yearly Profit, Operating, Gross MarginsJBTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), JBTM is destroying value.
  • JBTM has about the same amout of shares outstanding than it did 1 year ago.
  • JBTM has more shares outstanding than it did 5 years ago.
  • JBTM has a worse debt/assets ratio than last year.
JBTM Yearly Shares OutstandingJBTM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
JBTM Yearly Total Debt VS Total AssetsJBTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • JBTM has an Altman-Z score of 1.99. This is not the best score and indicates that JBTM is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of JBTM (1.99) is worse than 66.67% of its industry peers.
  • JBTM has a debt to FCF ratio of 6.97. This is a slightly negative value and a sign of low solvency as JBTM would need 6.97 years to pay back of all of its debts.
  • JBTM has a Debt to FCF ratio (6.97) which is comparable to the rest of the industry.
  • JBTM has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.43, JBTM is in line with its industry, outperforming 55.30% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 6.97
Altman-Z 1.99
ROIC/WACC0.21
WACC9.32%
JBTM Yearly LT Debt VS Equity VS FCFJBTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 0.93 indicates that JBTM may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.93, JBTM is doing worse than 89.39% of the companies in the same industry.
  • JBTM has a Quick Ratio of 0.93. This is a bad value and indicates that JBTM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • JBTM has a Quick ratio of 0.53. This is amonst the worse of the industry: JBTM underperforms 88.64% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.53
JBTM Yearly Current Assets VS Current LiabilitesJBTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 27.08% over the past year.
  • Measured over the past 5 years, JBTM shows a small growth in Earnings Per Share. The EPS has been growing by 0.52% on average per year.
  • JBTM shows a strong growth in Revenue. In the last year, the Revenue has grown by 92.43%.
  • The Revenue has been decreasing by -2.48% on average over the past years.
EPS 1Y (TTM)27.08%
EPS 3Y8.17%
EPS 5Y0.52%
EPS Q2Q%29.33%
Revenue 1Y (TTM)92.43%
Revenue growth 3Y7%
Revenue growth 5Y-2.48%
Sales Q2Q%120.65%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.91% on average over the next years. This is a very strong growth
  • JBTM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.83% yearly.
EPS Next Y25.32%
EPS Next 2Y24.33%
EPS Next 3Y23.91%
EPS Next 5YN/A
Revenue Next Year117.04%
Revenue Next 2Y50.56%
Revenue Next 3Y33.89%
Revenue Next 5Y4.83%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
JBTM Yearly Revenue VS EstimatesJBTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
JBTM Yearly EPS VS EstimatesJBTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 25.81, which means the current valuation is very expensive for JBTM.
  • JBTM's Price/Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Earnings ratio is at 27.32. JBTM is around the same levels.
  • Based on the Price/Forward Earnings ratio of 19.97, the valuation of JBTM can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, JBTM is valued a bit cheaper than the industry average as 60.61% of the companies are valued more expensively.
  • JBTM's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.32.
Industry RankSector Rank
PE 25.81
Fwd PE 19.97
JBTM Price Earnings VS Forward Price EarningsJBTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of JBTM indicates a slightly more expensive valuation: JBTM is more expensive than 68.18% of the companies listed in the same industry.
  • JBTM's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 29.91
EV/EBITDA 25.39
JBTM Per share dataJBTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

  • JBTM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • JBTM's earnings are expected to grow with 23.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.02
PEG (5Y)49.84
EPS Next 2Y24.33%
EPS Next 3Y23.91%

3

5. Dividend

5.1 Amount

  • JBTM has a yearly dividend return of 0.25%, which is pretty low.
  • JBTM's Dividend Yield is comparable with the industry average which is at 0.98.
  • Compared to an average S&P500 Dividend Yield of 1.83, JBTM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.25%

5.2 History

  • The dividend of JBTM has a limited annual growth rate of 0.48%.
  • JBTM has been paying a dividend for over 5 years, so it has already some track record.
  • JBTM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.48%
Div Incr Years0
Div Non Decr Years4
JBTM Yearly Dividends per shareJBTM Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

  • The earnings of JBTM are negative and hence is the payout ratio. JBTM will probably not be able to sustain this dividend level.
  • The dividend of JBTM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-17.36%
EPS Next 2Y24.33%
EPS Next 3Y23.91%
JBTM Yearly Income VS Free CF VS DividendJBTM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

JBT MAREL CORP

NYSE:JBTM (1/22/2026, 8:04:00 PM)

After market: 157.42 0 (0%)

157.42

-0.71 (-0.45%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-03
Earnings (Next)05-04
Inst Owners99.18%
Inst Owner ChangeN/A
Ins Owners0.63%
Ins Owner Change-8.81%
Market Cap8.18B
Revenue(TTM)3.26B
Net Income(TTM)-110.60M
Analysts83.33
Price Target159.94 (1.6%)
Short Float %5.38%
Short Ratio5.72
Dividend
Industry RankSector Rank
Dividend Yield 0.25%
Yearly Dividend0.41
Dividend Growth(5Y)0.48%
DP-17.36%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.24%
Min EPS beat(2)14.08%
Max EPS beat(2)26.4%
EPS beat(4)3
Avg EPS beat(4)11.49%
Min EPS beat(4)-8.58%
Max EPS beat(4)26.4%
EPS beat(8)5
Avg EPS beat(8)4.11%
EPS beat(12)9
Avg EPS beat(12)6.09%
EPS beat(16)11
Avg EPS beat(16)6.44%
Revenue beat(2)2
Avg Revenue beat(2)3.62%
Min Revenue beat(2)2.12%
Max Revenue beat(2)5.11%
Revenue beat(4)3
Avg Revenue beat(4)0.28%
Min Revenue beat(4)-6.26%
Max Revenue beat(4)5.11%
Revenue beat(8)4
Avg Revenue beat(8)-1.54%
Revenue beat(12)4
Avg Revenue beat(12)-4.62%
Revenue beat(16)5
Avg Revenue beat(16)-3.94%
PT rev (1m)3.98%
PT rev (3m)9.04%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.19%
EPS NY rev (1m)0%
EPS NY rev (3m)6.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.9%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.75%
Valuation
Industry RankSector Rank
PE 25.81
Fwd PE 19.97
P/S 2.51
P/FCF 29.91
P/OCF 23.16
P/B 1.85
P/tB N/A
EV/EBITDA 25.39
EPS(TTM)6.1
EY3.87%
EPS(NY)7.88
Fwd EY5.01%
FCF(TTM)5.26
FCFY3.34%
OCF(TTM)6.8
OCFY4.32%
SpS62.69
BVpS85.06
TBVpS-22.35
PEG (NY)1.02
PEG (5Y)49.84
Graham Number108.05
Profitability
Industry RankSector Rank
ROA -1.35%
ROE -2.5%
ROCE 2.39%
ROIC 1.95%
ROICexc 1.98%
ROICexgc 10.75%
OM 4.81%
PM (TTM) N/A
GM 35.8%
FCFM 8.4%
ROA(3y)9.73%
ROA(5y)8.16%
ROE(3y)19.95%
ROE(5y)18.56%
ROIC(3y)5.49%
ROIC(5y)6.97%
ROICexc(3y)7.1%
ROICexc(5y)8.09%
ROICexgc(3y)24.27%
ROICexgc(5y)25.88%
ROCE(3y)6.33%
ROCE(5y)8.04%
ROICexgc growth 3Y-1.29%
ROICexgc growth 5Y-6.67%
ROICexc growth 3Y-5.85%
ROICexc growth 5Y-12.74%
OM growth 3Y-9.42%
OM growth 5Y-7.55%
PM growth 3Y-16.35%
PM growth 5Y-5.58%
GM growth 3Y1.99%
GM growth 5Y3.46%
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 6.97
Debt/EBITDA 5.04
Cap/Depr 36%
Cap/Sales 2.45%
Interest Coverage 250
Cash Conversion 93.41%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.53
Altman-Z 1.99
F-Score3
WACC9.32%
ROIC/WACC0.21
Cap/Depr(3y)71.26%
Cap/Depr(5y)66.65%
Cap/Sales(3y)3.61%
Cap/Sales(5y)3.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.08%
EPS 3Y8.17%
EPS 5Y0.52%
EPS Q2Q%29.33%
EPS Next Y25.32%
EPS Next 2Y24.33%
EPS Next 3Y23.91%
EPS Next 5YN/A
Revenue 1Y (TTM)92.43%
Revenue growth 3Y7%
Revenue growth 5Y-2.48%
Sales Q2Q%120.65%
Revenue Next Year117.04%
Revenue Next 2Y50.56%
Revenue Next 3Y33.89%
Revenue Next 5Y4.83%
EBIT growth 1Y-4.04%
EBIT growth 3Y-3.08%
EBIT growth 5Y-9.84%
EBIT Next Year200.73%
EBIT Next 3Y57.42%
EBIT Next 5YN/A
FCF growth 1Y328.68%
FCF growth 3Y4%
FCF growth 5Y22.04%
OCF growth 1Y167.78%
OCF growth 3Y1.15%
OCF growth 5Y16.21%

JBT MAREL CORP / JBTM FAQ

Can you provide the ChartMill fundamental rating for JBT MAREL CORP?

ChartMill assigns a fundamental rating of 3 / 10 to JBTM.


What is the valuation status of JBT MAREL CORP (JBTM) stock?

ChartMill assigns a valuation rating of 3 / 10 to JBT MAREL CORP (JBTM). This can be considered as Overvalued.


How profitable is JBT MAREL CORP (JBTM) stock?

JBT MAREL CORP (JBTM) has a profitability rating of 3 / 10.


What is the financial health of JBT MAREL CORP (JBTM) stock?

The financial health rating of JBT MAREL CORP (JBTM) is 2 / 10.


How sustainable is the dividend of JBT MAREL CORP (JBTM) stock?

The dividend rating of JBT MAREL CORP (JBTM) is 3 / 10 and the dividend payout ratio is -17.36%.